Early-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday.
FILE PHOTO: The logo for pharmaceutical company AstraZeneca at the New York Stock Exchange in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
“We expect this paper, which is undergoing final editing and preparation, to be published on Monday, July 20, for immediate release,” a spokeswoman for the journal said. Developers of the vaccine, known as known as AZD1222, said earlier this month they were encouraged by the immune response they had seen in trials so far and were expecting to publish Phase 1 data by the end of July.
More than 100 vaccines are being developed and tested around the world to try to stop the COVID-19 pandemic, which has killed hundreds of thousands and ravaged the global economy.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Early-stage trial data on AstraZeneca COVID-19 vaccine due July 20 - LancetThe Lancet medical journal said on Wednesday it will publish keenly-awaited phase 1 clinical trial data on a potential COVID-19 vaccine being developed by Astrazeneca and Oxford University on Monday.
Read more »
Potential COVID-19 vaccine shows promise in early trial'It is good news that it's not bad news,' infectious disease expert Dr. Michael Osterholm says about promising results from Moderna's first COVID-19 vaccine trial. 'But remember, we're in the first 100 yards of a marathon.'
Read more »
Moderna's COVID vaccine candidate appears to be safe and provide some immunity, new data from early trial showsIt's too early to say if the vaccine candidate can protect someone from the coronavirus that causes COVID-19, but early trials are encouraging.
Read more »
Moderna's COVID-19 vaccine candidate appears to be safe and provide some immunity, new data from early trial showsIt's too early to say whether the vaccine candidate can protect someone from the coronavirus that causes COVID-19, but early trials are encouraging.
Read more »
Israel took strong early steps against Covid-19, but now the virus is resurging and some say the country reopened too soonIsrael took strong early steps against Covid-19, but now the virus is resurging and some say the country reopened too soon.
Read more »
Stocks up after early, encouraging results in vaccine trialStocks open broadly higher on Wall Street following encouraging news about a possible coronavirus vaccine. The stock of drug company Moderna, which is developing the vaccine with the National Institutes of Health, rose sharply in the early going.
Read more »